We are IntechOpen, the world's leading publisher of Open Access books Built by scientists, for scientists

6,200+

Open access books available

169,000+

International authors and editors

185M+ Downloads

156 Countries delivered to Our authors are among the

Top 1% most cited scientists

12.2%

Contributors from top 500 universities

Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI)

### Interested in publishing with us? Contact book.department@intechopen.com

Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com

## Meet the editor

Dr. Rajeev K. Tyagi has been leading a group at CSIR-Institute of Microbial Technology, Chandigarh, India. He obtained his Ph.D. in 2011 at the Biomedical Parasitology Unit, Institute Pasteur, Paris, where he developed a long-lasting, stable and straightforward laboratory animal model (humanized mouse model). Dr. Tyagi's post-doctoral work was carried out at the University of South Florida, Augusta University and Vanderbilt

University Medical Center (VUMC), USA, where he used the humanized mouse model as a tool to study the infectious disease *P. falciparum* and inflammatory diseases (*P. gingivalis,* colitis). His current research group is working on the development of human-liver chimeric mice for huHep transplantation, the antimalarial and anti-inflammatory potential of oleuropein has been explored in the asexual blood stage infection of *P. falciparum* and in-vitro models of inflammation (LPSstimulated human THP-1 macrophages), and. on formulation and characterization of nanoscale drug carriers to deliver methotrexate (MTX) and aceclofenac in the treatment of rheumatoid arthritis, breast cancer and other inflammatory diseases.

### Contents


**Chapter 7 99** Liposomes for Targeting RNA Interference-Based Therapy in Inflammatory Bowel Diseases *by Iman M. Alfagih*
